Symbol | Exchange | Currency |
|---|
Jaguar Health, Inc. (JAGX) and its wholly owned subsidiary Napo Pharmaceuticals (Napo) today announced that Dr. Kelly Shanahan, a former clinician and a metastatic breast cancer...
Crofelemer was previously granted Orphan Drug Designation by the FDA for short bowel syndrome Jaguar Health (JAGX) today announced that the U.S. Food and Drug Administration (FDA)...
Jaguar Health (JAGX) granted FDA Orphan Drug Designation for Crofelemer for treatment of microvillus inclusion diseas
2023, before the market opens.Regarding Q4 estimates, Wall Street analysts expect Jaguar Animal Health Inc. to post earnings of -$9.75 per share. Revenue expectations are pegged at...
Jaguar Health, Inc. is a commercial stage pharmaceutical company. The Company is focused on developing plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with gastrointestinal (GI) distress, including chronic and debilitating diarrhea. The Company operates through two segments: human health and animal health. The animal health segment is focused on developing and commercializing prescription and non-prescription products for companion and production animals. Its Canalevia-CA1 is used for chemotherapy-induced diarrhea in dogs. The human health segment is focused on developing and commercializing of human products and the ongoing commercialization of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS) on antiretroviral therapy. Its wholly owned subsidiary is Napo Pharmaceuticals, Inc.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Neutral | Buy | Sell | Strong Sell |
| Technical Indicators | Strong Sell | Buy | Strong Buy | Strong Sell | Sell |
| Summary | Strong Sell | Neutral | Strong Buy | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 151.80 | 153.40 | 151.40 | -1.60 | -1.04% | 2.60M | London | |||
| 215.00 | 221.00 | 210.00 | -5.00 | -2.27% | 624.35K | London | |||
| 133.90 | 137.74 | 130.06 | -5.88 | -4.21% | 122.87M | London | |||
| 1,030.00 | 1,030.00 | 1,030.00 | 0.00 | 0.00% | 30.79K | London | |||
| 103.05 | 104.30 | 102.30 | -1.70 | -1.62% | 24.54M | London | |||
| 222.50 | 224.50 | 220.00 | -2.50 | -1.11% | 312.84K | London | |||
| 0.1275 | 0.132 | 0.1305 | -0.0085 | -6.25% | 382.90M | London | |||
| 478.50 | 492.00 | 473.00 | -12.00 | -2.45% | 66.67K | London | |||
| 1,100.00 | 1,160.00 | 1,079.00 | -40.00 | -3.51% | 289.75K | London | |||
| 88.58 | 90.78 | 88.16 | -2.22 | -2.44% | 55.26M | London | |||
| 12.25 | 12.70 | 12.00 | +0.25 | +2.08% | 738.23K | London | |||
| 362.50 | 362.50 | 362.50 | -2.50 | -0.69% | 50.84K | London | |||
| 0.12 | 0.13 | 0.13 | 0.00 | 0.00% | 0.00 | Aquis Exchange | |||
| 94.50 | 92.40 | 92.40 | +2.10 | +2.27% | 193.60K | London | |||
| 1,100.00 | 1,110.00 | 1,088.00 | -6.00 | -0.54% | 110.44K | London |